Cargando…

Identification of a three-m6A related gene risk score model as a potential prognostic biomarker in clear cell renal cell carcinoma

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is one of the most prevalent malignancies worldwide, N6-methyladenosine (m6A) has been shown to play important roles in regulating gene expression and phenotypes in both health and disease. Here, our purpose is to construct a m6A-regulrator-based r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yiqiao, Tao, Zijia, Chen, Xiaonan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2020
Materias:	Bioinformatics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085294/ https://www.ncbi.nlm.nih.gov/pubmed/32219036 http://dx.doi.org/10.7717/peerj.8827

Ejemplares similares

Identification of the miRNA-mRNA regulatory pathways and a miR-21-5p based nomogram model in clear cell renal cell carcinoma
por: Zhao, Yiqiao, et al.
Publicado: (2020)

A Three-Metabolic-Genes Risk Score Model Predicts Overall Survival in Clear Cell Renal Cell Carcinoma Patients
por: Zhao, Yiqiao, et al.
Publicado: (2020)

Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma
por: Ma, Wei, et al.
Publicado: (2021)

Prognostic significance and tumor-immune infiltration of mTOR in clear cell renal cell carcinoma
por: Li, Na, et al.
Publicado: (2021)

AURKB: a promising biomarker in clear cell renal cell carcinoma
por: Wan, Bangbei, et al.
Publicado: (2019)

Identification of DNA methylation patterns and biomarkers for clear-cell renal cell carcinoma by multi-omics data analysis
por: Liu, Pengfei, et al.
Publicado: (2020)

Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinoma
por: Fan, Demin, et al.
Publicado: (2020)

Prognostic value of sirtuin family members and experimental verification identify SIRT5 as diagnostic biomarkers in clear cell renal cell carcinoma
por: Peng, Lu-Shan, et al.
Publicado: (2023)

Prognostic Characteristics and Immune Effects of N(6)-Methyladenosine and 5-Methylcytosine-Related Regulatory Factors in Clear Cell Renal Cell Carcinoma
por: Li, Lei, et al.
Publicado: (2022)

Profiles of overall survival-related gene expression-based risk signature and their prognostic implications in clear cell renal cell carcinoma
por: He, Zihao, et al.
Publicado: (2020)

Integrated bioinformatics analysis of the NEDD4 family reveals a prognostic value of NEDD4L in clear-cell renal cell cancer
por: Zhao, Hui, et al.
Publicado: (2021)

Identification and validation of a three-gene signature as a candidate prognostic biomarker for lower grade glioma
por: Xiao, Kai, et al.
Publicado: (2020)

Key genes associated with prognosis and metastasis of clear cell renal cell carcinoma
por: Zhong, Tingting, et al.
Publicado: (2022)

A united risk model of 11 immune‑related gene pairs and clinical stage for prediction of overall survival in clear cell renal cell carcinoma patients
por: Tao, Zijia, et al.
Publicado: (2021)

Novel prognostic prediction model constructed through machine learning on the basis of methylation-driven genes in kidney renal clear cell carcinoma
por: Tang, Weihao, et al.
Publicado: (2020)

Comprehensive analysis of a new prognosis signature based on histone deacetylases in clear cell renal cell carcinoma
por: Cheng, Fajuan, et al.
Publicado: (2021)

A novel gene signature related to oxidative stress predicts the prognosis in clear cell renal cell carcinoma
por: Ma, Sheng, et al.
Publicado: (2023)

Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma
por: Ju, Lincheng, et al.
Publicado: (2022)

Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis
por: Fu, Yang, et al.
Publicado: (2019)

IQGAP3 in clear cell renal cell carcinoma contributes to drug resistance and genome stability
por: Li, Wen, et al.
Publicado: (2022)

A 14 immune-related gene signature predicts clinical outcomes of kidney renal clear cell carcinoma
por: Zou, Yong, et al.
Publicado: (2020)

A microRNA‐clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma
por: Zhan, Yating, et al.
Publicado: (2021)

Downregulation of PPA2 expression correlates with poor prognosis of kidney renal clear cell carcinoma
por: Zhu, Wenbiao, et al.
Publicado: (2021)

Bioinformatic analysis identifies potentially key differentially expressed genes in oncogenesis and progression of clear cell renal cell carcinoma
por: Zhang, Haiping, et al.
Publicado: (2019)

Identification of an 8-miRNA signature as a potential prognostic biomarker for glioma
por: Ji, Baowei, et al.
Publicado: (2020)

NFIB promotes the migration and progression of kidney renal clear cell carcinoma by regulating PINK1 transcription
por: Wang, Ninghua, et al.
Publicado: (2021)

Identification of KIF4A as a pan-cancer diagnostic and prognostic biomarker via bioinformatics analysis and validation in osteosarcoma cell lines
por: Pan, Jiankang, et al.
Publicado: (2021)

Genome-wide analysis of lncRNAs, miRNAs, and mRNAs forming a prognostic scoring system in esophageal squamous cell carcinoma
por: Shi, Xiaobo, et al.
Publicado: (2020)

Predicting biochemical-recurrence-free survival using a three-metabolic-gene risk score model in prostate cancer patients
por: Zhao, Yiqiao, et al.
Publicado: (2022)

Microenvironment-related gene TNFSF13B predicts poor prognosis in kidney renal clear cell carcinoma
por: Jiang, Mingzhe, et al.
Publicado: (2020)

Identification of SPRR3 as a novel diagnostic/prognostic biomarker for oral squamous cell carcinoma via RNA sequencing and bioinformatic analyses
por: Yu, Lu, et al.
Publicado: (2020)

Key sunitinib‐related biomarkers for renal cell carcinoma
por: Peng, Yun, et al.
Publicado: (2021)

Identification of a three-gene-based prognostic model in multiple myeloma using bioinformatics analysis
por: Pan, Ying, et al.
Publicado: (2021)

Identification of Biomarkers Controlling Cell Fate In Blood Cell Development
por: Nazarieh, Maryam, et al.
Publicado: (2021)

Reduced GRAMD1C expression correlates to poor prognosis and immune infiltrates in kidney renal clear cell carcinoma
por: Hao, Haiyan, et al.
Publicado: (2019)

Identification of HMMR as a prognostic biomarker for patients with lung adenocarcinoma via integrated bioinformatics analysis
por: Li, Zhaodong, et al.
Publicado: (2021)

Prediction and analysis of novel key genes ITGAX, LAPTM5, SERPINE1 in clear cell renal cell carcinoma through bioinformatics analysis
por: Sui, Yingli, et al.
Publicado: (2021)

Cell division cycle proteinising prognostic biomarker of breast cancer
por: Cheng, Lin, et al.
Publicado: (2020)

Identification of potential diagnostic and prognostic biomarkers for LUAD based on TCGA and GEO databases
por: Zheng, Qiangqiang, et al.
Publicado: (2021)

GBP2 as a potential prognostic biomarker in pancreatic adenocarcinoma
por: Liu, Bo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tfru8052933bel9bcl70vc42qv